Home / Business and Economy / AI Mental Health Leader Takes HoloMD Helm
AI Mental Health Leader Takes HoloMD Helm
27 Oct
Summary
- Irene Lang, former Eliza CEO, appointed HoloMD CEO.
- Lang brings AI, mental health, and commercialization expertise.
- HoloMD aims to advance Continuous Precision Psychiatry with AI.
HoloMD has announced the appointment of Irene Lang as its new Chief Executive Officer and Cofounder, effective October 27, 2026. Lang, an entrepreneur with a background in AI and mental health technology, previously co-founded Eliza, which was acquired by Spring Health. She will lead HoloMD's next growth phase, focusing on its Dr. Holo™ platform for Continuous Precision Psychiatry.
Founder Bruce Alan Kehr, M.D., will transition to the role of Chief Medical Innovation Officer. Kehr expressed confidence in Lang's ability to scale adoption and attract capital, stating her expertise complements his decades of experience in precision psychiatry. Lang aims to leverage her product development and commercialization skills to make Continuous Precision Psychiatry the standard of care.
The company has demonstrated early success with a paid pilot program through Banyan Treatment Centers, showing high patient retention and actionable risk detection. HoloMD, recognized for its innovation, is now poised to advance its commercialization strategy and seek investment for future growth.
